Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Clinical pearls in general internal medicine 2012.

Bundrick JB, Litin SC.

Mayo Clin Proc. 2013 Jan;88(1):106-12. doi: 10.1016/j.mayocp.2012.11.003. No abstract available.

PMID:
23274023
2.

Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold.

Eccles R, Martensson K, Chen SC.

Curr Med Res Opin. 2010 Apr;26(4):889-99. doi: 10.1185/03007991003648015. Review.

PMID:
20151787
3.

[Rhinitis acuta: therapeutic approach with oxymetazoline].

Tüttenberg A.

MMW Fortschr Med. 2010 Apr 8;152 Suppl 1:16-20. German. No abstract available.

PMID:
20942303
4.

Effectiveness of topical nasal decongestants.

Connell JT.

Ann Allergy. 1969 Nov;27(11):541-6. No abstract available.

PMID:
4195892
5.

Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies.

Kim KT, Kerwin E, Landwehr L, Bernstein JA, Bruner D, Harris D, Drda K, Wanger J, Wood CC; Pediatric Atrovent Nasal Spray Study Group.

Ann Allergy Asthma Immunol. 2005 Jan;94(1):73-9.

PMID:
15702820
6.

Oxymetazoline nasal spray.

Graf P.

Laryngoscope. 1998 Aug;108(8 Pt 1):1255. No abstract available.

PMID:
9707257
7.

Not Just a Drop in the Bucket-Inversion of Oxymetazoline Nasal Decongestant Container Increases Potential for Severe Pediatric Poisoning.

Nordt SP, Vivero LE, Cantrell FL.

J Pediatr. 2016 Jan;168:240-1. doi: 10.1016/j.jpeds.2015.09.067. Epub 2015 Oct 30.

PMID:
26522979
8.

Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis.

Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR.

Rhinology. 2003 Sep;41(3):167-74.

PMID:
14579657
10.

Combined intranasal ipratropium bromide and oxymetazoline in experimental rhinovirus infection.

Pitkäranta A, Wecker MT, Korts DC, Hayden FG.

Am J Rhinol. 1998 Mar-Apr;12(2):125-9.

PMID:
9578931
11.

Acute coronary syndrome after nasal spray of oxymetazoline.

Montastruc F, Montastruc G, Taudou MJ, Olivier-Abbal P, Montastruc JL, Bondon-Guitton E.

Chest. 2014 Dec;146(6):e214-e215. doi: 10.1378/chest.14-1873. No abstract available.

PMID:
25451367
12.

Effectiveness and safety of intranasal ipratropium bromide in common colds. A randomized, double-blind, placebo-controlled trial.

Hayden FG, Diamond L, Wood PB, Korts DC, Wecker MT.

Ann Intern Med. 1996 Jul 15;125(2):89-97.

PMID:
8678385
13.

Efficacy and safety of intranasal xylometazoline and ipratropium in patients with common cold.

Graf P, Eccles R, Chen S.

Expert Opin Pharmacother. 2009 Apr;10(5):889-908. doi: 10.1517/14656560902783051 . Review. Erratum in: Expert Opin Pharmacother. 2009 Jun;10(8):1387.

PMID:
19351236
14.
15.

A comparative analysis of the decongestive effect of oxymetazoline and xylometazoline in healthy subjects.

Eskiizmir G, Hirçin Z, Ozyurt B, Unlü H.

Eur J Clin Pharmacol. 2011 Jan;67(1):19-23. doi: 10.1007/s00228-010-0941-z. Epub 2010 Nov 11.

PMID:
21069518
16.

Clinical pearls in general internal medicine.

Bundrick JB, Litin SC.

Mayo Clin Proc. 2011 Jan;86(1):70-4. doi: 10.4065/mcp.2010.0462. No abstract available.

17.

Decreased rhinovirus shedding after intranasal oxymetazoline application in adults with induced colds compared with intranasal saline.

Winther B, Buchert D, Turner RB, Hendley JO, Tschaikin M.

Am J Rhinol Allergy. 2010 Sep-Oct;24(5):374-7. doi: 10.2500/ajra.2010.24.3491.

PMID:
21244738
18.

Intranasal ipratropium bromide for the common cold.

Albalawi ZH, Othman SS, Alfaleh K.

Cochrane Database Syst Rev. 2011 Jul 6;(7):CD008231. doi: 10.1002/14651858.CD008231.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD008231.

PMID:
21735425
19.

Nasal airway resistance after decongestion with a nasal spray or a bellows device.

Jessen M, Ivarsson A, Malm L.

Rhinology. 1996 Mar;34(1):28-31.

PMID:
8739865
20.

[Decongestant nasal spray. Results of a rhinomanometric double-blind study].

Maranta CA, Simmen D.

Schweiz Med Wochenschr. 1996 Nov 2;126(44):1875-80. German. Erratum in: Schweiz Med Wochenschr 1996 Nov 30;126(48):2104.

PMID:
8984600

Supplemental Content

Support Center